Most vaccines and biologics must stay cold until ready for use, but new thin film technology stabilizes these therapeutics for months at room temperature.
As self-assembling structures, DNA and RNA origami vaccines hold vaccine components in precise numbers and arrangements to help the immune system attack tumors.
After tragedy struck during a 1960s clinical trial, development of a vaccine for RSV ground to a halt. But as new RSV vaccine candidates enter late-stage clinical trials, a safe and effective vaccine is finally in sight.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.